Ashwagandha, Withania somnifera (L.) Dunal, for the prophylaxis against SARS-CoV-2 infection: A multicentric randomized hydroxychloroquine controlled clinical trial in Indian health care workers

Ashwagandha, Withania somnifera (L.) Dunal, for the prophylaxis against SARS-CoV-2 infection: A multicentric randomized hydroxychloroquine controlled clinical trial in Indian health care workers

Background: The study was planned when, the hydroxychloroquine (HCQ) was the only prophylactic agent approved by health authorities in several countries and no prophylactic COVID-19 vaccine was available. Objective: The present study aimed to evaluate efficacy of Withania Somnifera (L.) Dunal (WS) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Renuka Kulkarni-Munshi, Deepti Talmohite, Anand More, Jaya Chakravarty, Sandhya Kamat, Akash Khobragade, D. Himanshu Reddy, Manish Patel, Divya Kajaria, Raju Singh, Sarita Kumari, Priyanka Mishra, A.K. Srivastava, Vivek Bhagat, Saurabh Pandey, Meena Yadav, Rahul Darnule, Shobha Bhat, Sangeeta Kansal, Sonali Munot, Dipti Kumbhar, Raakhi Tripathi, Snehalata Gajbhiye, Padmaja Marathe, Jaee Parvatkar, Dhaiwat Shukla, Prakashkumar Panchal, Jui Shah, Jayashree Bhale, Viswajanani Sattigeri, Ashish Amarsheda, Anil Avhad, Nilima Kshirsagar, Dilip M. Mondhe, Arvind Chopra
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of Ayurveda and Integrative Medicine
Subjects:
Ashwagandha
COVID-19
Health care workers
Hydroxychloroquine
India
Prophylaxis
Online Access:http://www.sciencedirect.com/science/article/pii/S0975947625000117
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items